|
Our Services
The Division of Hematology and Oncology in
the Department of Medicine provides comprehensive hematology
and medical oncology services. The Division, with its colleagues
in other medical specialties, form the Massachusetts General
Hospital Cancer Center, one of the leading cancer treatment
and research facilities in New England. The Cancer Center
is a founding member of Dana-Farber/Partners CancerCare - a
collaboration in adult oncology among Massachusetts General
Hospital, Dana-Farber Cancer Institute, and Brigham and Women's
Hospital. It is a member of the Dana-Farber/Harvard Cancer
Center, which has been designated by the National Cancer
Institute as a Comprehensive Cancer Center.
The Division of Hematology and Medical
Oncology offers:
- benign and malignant
hematology and solid tumor oncology
- High-dose
chemotherapy
- Autologous and
Allogeneic stem cell rescue -
subjects of major research efforts
- New
treatments including trials in
gene therapy and vaccine therapy
as well as innovative approaches
in stem cell transplantation
The
institution has made a significant
investment in resources designed to enhance
clinical research and patient
comfort and support.
The Cancer Center provides a full breadth
of clinical and support services to patients,
family members, and friends through a
variety of multidisciplinary clinical
programs focused on specific types of
cancer. Members of the Division are all subspecialists;
experts who focus exclusively on a specific
category of diseases (such as lung or
breast cancer).
Our bone marrow transplant
specialists are recognized authorities
in their field and work closely
with our multidisciplinary clinical programs
to bring our patients considerable
knowledge and experience. Patients are
treated in the outpatient Infusion Unit
and inpatient floors and, when appropriate,
in coordination with the on-site
radiation therapy and surgical services.
In order to provide the best possible care to the patient,
the patient's evaluation and treatment is managed by members
of individual multidisciplinary clinical cancer programs that
are organized by cancer diagnosis. The participation of patients
in these multidisciplinary programs assures patient access
to national, multi-institutional clinical trials as well as
those developed and exclusively offered at the Cancer Center.
The members of the Division of Hematology and Medical Oncology
participate in the following clinical programs:
Research
Research is an essential part of the Cancer Center's
mission. For more than 70 years, the Massachusetts General
Hospital has been involved in clinical and basic research
related to cancer.
We conduct research into the causes and mechanisms of cancer,
with an emphasis on translating that work to clinical application,
so that we can offer patients the benefits of these advances.
Research at the Cancer Center focuses on exploring fundamental
pathways which are critically altered in tumor cells, and
in identifying novel genes that are central to both development
and cancer.
The Center
for Cancer Research in Charlestown
is the basic research arm of our Cancer
Center, specifically the close interactions
which exist with the Division of Hematology
and Medical Oncology. Fifteen laboratories
on the same floor interact closely in
the exploration of signaling and developmental
pathways. There is a continuous exchange
of ideas between investigators who pursue
related issues in organisms that include
yeast, fruitflies, worms, mice, and of
course man. This group is widely recognized
as one of the leading centers exploring
the use of model organisms as genetic
tools to elucidate pathways of importance
in human cancer.
The Center for
Cancer Risk Analysis is an integral part of this center
and it plays a vital role in examining the clinical relevance
of mutations in genes that contribute to tumor generation.
Medical
Education
The Hematology and Medical Oncology fellowships spend
six months in advanced clinical training at Massachusetts
General Hospital Cancer Center and six months at the Dana-Farber/Brigham
and Women's Hospital with exposure to each of the 13 treatment
programs.
Read more
>>>
|
